Hypertrophic cardiomyopathy trials in France

In France 8 Also abroad 88

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
Where
Montpellier, Paris, Saint-Herblain
Age
18 years and over
People
130 worldwide
Run by
Imbria Pharmaceuticals Inc.
See details and how to join2024-515125-28-00 · EU 2024-515125-28-00
Phase 2Taking people
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Where
Montpellier, Paris, Saint-Herblain
Age
18 years and over
People
165 worldwide
Run by
Imbria Pharmaceuticals, Inc.
See details and how to joinNCT07023614
Phase 2/3Enrolling by invitation
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
Where
Marseille, Montpellier, Paris, Paris Cedex 15, Pessac, Rennes, Saint-Herblain, Toulouse Cedex 9
Age
18 years to 85 years
People
900 worldwide
Run by
Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00
No phaseTaking people
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Where
Amiens, Haguenau, Lille, Montpellier, Poitiers, Saint-Herblain, Toulon
Age
18 years and over
People
1,700 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05489705
Phase 3Taking people
LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.
Where
Angers, Bordeaux, Brest, Caen, Dijon, Grenoble, Lille, Marseille, Nantes, Paris, Rennes, Rouen, Toulouse, Tours, Vandœuvre-lès-Nancy
Age
40 years to 80 years
People
532
Run by
Rennes University Hospital
See details and how to joinNCT07202897 · EU 2024-511084-28-00
No phaseNot yet taking people in France
Biological Collection for the Purpose of Exploring Genetic and Clinical-biological Factors Associated With Variability in Response to Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy
Where
Boulogne-Billancourt, Le Kremlin-Bicêtre, Paris
Age
18 years and over
People
300
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07439952
No phaseTaking people
Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy
Where
Boulogne-Billancourt
Age
16 years and over
People
2,000
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT03846297
No phaseTaking people
French Hypertrophic Cardiomyopathy Observatory
Where
Paris
Age
15 years and over
People
600
Run by
French Cardiology Society
See details and how to joinNCT01091480